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The Wingless/Int1 (Wnt) signaling system plays multiple,
essential roles in embryonic development, tissue homeostasis,
and human diseases. Althoughmany of the underlying signaling
mechanisms are becoming clearer, the binding mode, kinetics,
and selectivity of 19 mammalianWNTs to their receptors of the
class Frizzled (FZD1–10) remain obscure. Attempts to investi-
gate Wnt-FZD interactions are hampered by the difficulties in
working with Wnt proteins and their recalcitrance to epitope
tagging. Here, we used a fluorescently tagged version of mouse
Wnt-3a for studying Wnt-FZD interactions. We observed that
the enhanced GFP (eGFP)-tagged Wnt-3a maintains properties
akin to wild-type (WT) Wnt-3a in several biologically relevant
contexts. The eGFP-taggedWnt-3a was secreted in an evenness
interrupted (EVI)/Wntless-dependent manner, activated Wnt/
b-catenin signaling in 2D and 3D cell culture experiments, pro-
moted axis duplication in Xenopus embryos, stimulated low-
density lipoprotein receptor-related protein 6 (LRP6) phospho-
rylation in cells, and associated with exosomes. Further, we used
conditioned medium containing eGFP-Wnt-3a to visualize its
binding to FZD and to quantify Wnt-FZD interactions in real
time in live cells, utilizing a recently established NanoBRET-
based ligand binding assay. In summary, the development of a
biologically active, fluorescent Wnt-3a reported here opens up
the technical possibilities to unravel the intricate biology of
Wnt signaling andWnt-receptor selectivity.
In metazoans, cell-to-cell communication is predominantly
controlled by the activation of specific cell surface receptors
localized within the plasma membrane. Receptor-activating
ligands are secreted from (paracrine) or presented on the sur-
face (cell contact) of neighboring cells or presented as a hu-
moral ligand with systemic effects (endocrine). Ligand-receptor
interaction initiates conformational changes in the receptor to
activate diverse intracellular signal transduction events that al-
ter cellular behavior in a context-specific manner. TheWnt sig-
naling system is an evolutionarily conserved, tightly regulated
signaling network comprised ofmultiple transmembrane recep-
tors and secreted ligands that play complex roles in embryonic
development and tissue homeostasis (1–3). Ten different G pro-
tein–coupled receptors of the class F (FZD1–10) engage with 19
different lipidated Wnt proteins with unknown ligand-receptor
selectivity to transduce Wnt signaling (1, 4–6). In addition to
FZDs, coreceptors for Wnts are usually associated with specific
branches of the pathway, such as low-density-lipoprotein-recep-
tor-related proteins 5 and 6 (LRP5/6) for Wnt/b-catenin signal-
ing (1). Pathway selectivity of Wnts is dictated by the relative
availability of specific receptors, coreceptors, andWnts, as well as
the relative binding affinities of ligand-receptor interactions (7).
Various biochemical assays have been used to investigate the
binding affinities of specificWnt-FZD pairs, andKd values rang-
ing from 5–100 nM have been reported in Drosophila, which
have 5Wnt and 4 FZD genes (7, 8). Such studies in higher verte-
brates have proven more challenging because of the increased
ligand-receptor diversity as well as difficulties associated with
the biochemistry and lipophilicity of Wnt proteins resulting in
low specific activity or a large proportion of nonspecific binding.
Nevertheless, binding affinities ranging from 100 nM (Wnt-4/
FZD2-CRD) down to 1.5 nM (Wnt-3a/FZD8-CRD) have also
been reported (9, 10). All of these studies used membrane-teth-
ered Wnts (7, 8) and/or the soluble, isolated cysteine-rich do-
main (CRD) of FZDs (8–10), which fail to fully recapitulate
native conditions for Wnt interaction with the full-length FZD
on live cells in real time.
Fluorescent labeling of proteins is a widely used and valued
technique because of the range of biophysical and biochemical
detection options it offers (11). However, the introduction of a
large fluorescent moiety into a protein often compromises the
stability and functionality of the target protein. A major limita-
tion for the study of Wnt signaling and receptor binding origi-
nates from the lipophilicity of the Wnts themselves, which
results in poor solubility and their recalcitrance to epitope tag-
ging. Only a few attempts to generate functional, fluorescently
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tagged Wnt proteins have met with some degree of success,
such as Xenopus Wnt-2b (12), Xenopus Wnt-5a (13), zebrafish
Wnt-8 (14), and chickWnt-1 (15), all of which are C-terminally
tagged. Farin et al. elegantly demonstrated that successful epi-
tope tagging of a mammalian Wnt is indeed possible after
reporting that mice harboring an internal HA tag inserted at
residue Q41 of theWnt-3a gene were viable and could produce
a fully functional, tractable Wnt-3a protein (16). Wnt-3a with
Flag inserted at the same position (Wnt-3a–iFlag) is secreted
from cells and binds to FZDs and LRP6 (17). More recently,
an N-terminal GFP-tagged version of mouse Wnt-3a (GFP-
Wnt-3a) was reported that is secreted from cells and shows
partial activity (18). Despite these advancements, studies
reporting quantitative analysis of the binding of a full-
length, soluble Wnt protein to a full-length FZD protein on
cells remain elusive.
Here, we describe a novel approach using full-length versions
of Wnt-3a and FZDs to study the biology and biophysics of re-
ceptor engagement in real time using living cells. A combina-
tion of two recent developments enabled this: 1) the availability
of a fluorescently tagged Wnt protein that is active, stable, and
secreted into the medium of cultured cells, and 2) a highly
sensitive proximity-based bioluminescence resonance energy
transfer (BRET) assay, termed NanoBRET (19), which relies on
resonance energy transfer from a cell surface-localized Nanolu-
ciferase (Nluc) to a nearby enhanced GFP (eGFP). Compared
with the standard luciferase from Renilla reniformis, Nluc from
the deep-sea shrimp Oplophorus gracilirostris is smaller and
brighter and has a spectrum reduced by ;20 nm, all of which
lends itself well to the precise study of ligand-receptor interac-
tions in the complex milieu of living cells (19, 20). Our analysis
of Wnt-3a binding to full-length FZD4 indicates that a high-af-
finity Wnt-FZD pair presents with a low-nanomolar equilib-
rium dissociation constant in living cells. Furthermore, we
identify Afamin-dependent differences in the association of
Wnt-3a with FZD4.
Results
Characterization of a functionally active eGFP-Wnt3a
Encouraged by recent reports of successful tagging of mouse
Wnt-3a (16–18), we generated eGFP-Wnt-3a with the aim of
utilizing this for ligand-receptor interaction studies. We fused
eGFP directly to the N terminus of Wnt-3a, which projects
away from the Wnt/FZD-CRD binding region (21, 22), using a
short peptide linker (Fig. 1a and Fig. S1a). Our construct is sim-
ilar to Flag-GFP-Wnt-3a generated by Takada et al. but lacks
the Flag epitope tag (18). We generated a stably expressing L-
cell line, which secretes biochemically stable eGFP-mWnt-3a
into themedium similarly toWTWnt-3a (Fig. 1b, lower panels,
and Fig. S1b). When the conditioned medium (CM) is tested
for functional activity using T-cell factor (TCF) reporter assays,
eGFP-Wnt-3a behaves like WT Wnt-3a when using NCI-
H1703 cells (Fig. 1b, upper graph). H1703 cells were chosen
because they display strong Wnt/b-catenin signaling activity
(23) and distinct cell surface expression of overexpressed Wnt
receptors. Using HEK293 cells, however, eGFP-Wnt-3a shows
only’20% activity of WTWnt-3a (Fig. 1b, upper right graph).
Transfection of LRP6 increased the basal Wnt activity of
HEK293 cells and, under these conditions, the activity of
eGFP-Wnt-3a relative to that of Wnt-3a increased from
’20% to ’60% (Fig. S1d). We next tested the ability of
eGFP-Wnt-3a CM to induce LRP6 phosphorylation, which
occurs in response to acute pathway stimulation (24, 25).
Similar to Wnt-3a CM, the addition of eGFP-Wnt-3a CM
to either HEK293 cells (Fig. 1c) or NCI-H1703 cells (Fig. S1,
d–e) promotes phosphorylation of endogenous LRP6, which
is accompanied by the characteristic upshift of the mature,
cell surface LRP6 protein band (Fig. 1c and Fig. S1d). Further,
we validated the activity of eGFP-Wnt-3a in vivo in Xenopus
embryos, which provides a physiologically relevant model
system for assessingWnt activity (26). Duplication of the pri-
mary embryonic axis is well known to be robustly induced by
Wnts (27), and mouse eGFP-Wnt-3a displays activities simi-
lar to those of untagged Wnt-3a in the axis duplication assay
(Fig. 1d). Wnt-3a/eGFP-Wnt-3a CMwas also prepared using
transiently transfected HEK293F suspension cells in serum-
free medium (Fig. S1e). The serum component Afamin binds
to Wnt-3a and aids its secretion and/or release from cells
into serum-free medium (28), and Afamin also improved
eGFP-Wnt-3a secretion (Fig. S1f). Taken together, these
results confirm that synthesis, secretion, stability, and signal-
ing activity of eGFP-Wnt-3a are largely preserved upon
fusion of the 25-kDa eGFP protein to the N terminus of
Wnt-3a.
eGFP-Wnt3a is secreted in an EVI-dependent manner and
associates with exosomes
Wnt proteins are acylated in the endoplasmic reticulum by
the palmitoyltransferase porcupine (29), and the Wnt-spe-
cific chaperone EVI/Wntless mediates subsequent transport
through the secretory pathway, which is necessary for correct
cell surface transportation and release of lipidatedWnts from
cells (30, 31). Since eGFP-Wnt-3a is efficiently secreted from
mammalian cells, we investigated whether secretion depends
on EVI/Wntless using DEVI mutant cells. Expression levels of
WT and eGFP-Wnt-3a are similar; however, neither is secreted
in DEVI mutant HEK293 cells (Fig. 2a). Another characteristic
of lipidatedWnt proteins is their trafficking in exosomes, which
is one mechanism that accounts for Wnt secretion (32, 33). In a
further confirmation of the functional similarity between WT
and fluorescently tagged Wnt-3a, exosomes purified from con-
ditioned medium associate with both Wnt-3a and eGFP-Wnt-
3a (Fig. 2b and Fig. S2). This was the case for exosomes purified
using either ultracentrifugation (Fig. 2b and Fig. S2) or mag-
netic-activated cell sorting antibody-based sorting (Fig. S2).
Exosomes were prepared from either HEK293 adherent cells in
serum-containing medium (Fig. 2b) or HEK293F suspension
cells in serum-freemedium (Fig. S2).
eGFP-Wnt-3a acts through FZDs to mediate WNT/b-catenin
signaling
Wnt-3a acts through FZDs and LRP5/6 to transduce Wnt/
b-catenin signaling manifested in the phosphorylation of LRP5/
6, phosphorylation of the scaffold protein Disheveled (DVL),
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stabilization of b-catenin, and transcriptional regulation of
TCF/LEF-dependent genes. Although endogenously expressed
FZDs in HEK293 cells are sufficient to mediateWNT/b-catenin
pathway activation, removal of FZD expression blunts Wnt-
induced signaling (34–37). To define the role of FZDs in the
eGFP-Wnt-3a-induced WNT/b-catenin response, we com-
pared the transcriptional response induced by untaggedWnt-3a
and eGFP-Wnt-3a in WT HEK293 cells or HEK293 cells
lacking FZD1,2,4,5,7,8 (35). The complete absence of a Wnt
response in FZD mutant HEK293 cells emphasizes that Wnt/
b-catenin signaling activated by eGFP-Wnt-3a is transduced
in an FZD-dependent manner (Fig. 2c). Transfection of FZD2
in the FZD mutant cells restores the ability of both untagged
Wnt-3a and eGFP-Wnt-3a to transduce WNT/b-catenin sig-
naling (Fig. 2c).
mCherry-Wnt-3a activates Wnt/b-catenin signaling at a
distance from its source
Extracellular dispersal of Wnt proteins contributes to signal-
ing events (38), and it is reported that Wnt-3a forms homotri-
meric complexes, with dynamic formation of larger structures
controlling the range with which Wnt proteins can diffuse
through the extracellular space (18). To study the diffusion of
our fluorescently tagged Wnt-3a, we developed a controllable,
microdroplet-based cell spheroid formation and fusion assay
(see Materials and methods for details), which provides a visual
readout of Wnt paracrine signaling. For the fluorescently
tagged Wnt-3a, spheroids are prepared from HEK293 cells
transfected with mCherry-Wnt-3a, which has an activity simi-
lar to that of eGFP-Wnt-3a (Fig. 3a). For the Wnt/b-catenin
signaling readout, we prepared spheroids of TOP-GFPHEK293
Figure 1. Generation of functionally active eGFP-Wnt-3a. a, Schematic overview of the eGFP-Wnt-3a fusion protein construct. For more details, refer to
Fig. S1a. The protein complex model depicts human Wnt-8 (violet) and the mouse FZD8-CRD (bronze) based on the crystal structure (PDB entry 6AHY). The N
terminus, where linker and eGFP are fused, is highlighted in red, and the C-terminal region is also indicated. The palmitoleoyl chain (PAM) is shown in yellow.
The model was created in PyMOL (The PyMOL Molecular Graphics System, version 2.0; Schrödinger, LLC). b, Western blotting (lower panels, anti-Wnt-3a anti-
body) and TOPFLASH TCF reporter assays (upper graphs) showing presence of soluble Wnt-3a and eGFP-Wnt-3a in conditioned medium (CM) from stable L-
cell lines and activity testing of the indicated CM in either NCI-H1703 or HEK293 cells, respectively. Note that CM is prepared using appropriatemedium for the
cell lines used (see Materials and methods for details). Error bars represent6 S.D. from means of 4 independent biological samples, represented as solid dots.
Experiments were performed 3 times with similar results. c, Western blots showing Wnt-dependent phosphorylation and associated upshift of endogenous
LRP6 protein bands from HEK293 cells after the addition of either Wnt-3a or eGFP-Wnt-3a L-cell CM, as indicated. The CM samples shown in b were used.
Experiments were repeated at least three times with similar results. d, Axis duplication assay in Xenopus laevis embryos; 2.5 ng of either WTWnt-3a or eGFP-
Wnt-3a mRNA was injected equatorially in both ventral blastomeres of 4-cell stage embryos. Embryos (n defines total number of embryos evaluated) were
scored for presence of a secondary axis the next day (stage 28), and error bars represent6 S.D. from means between three independent batches of injected
embryos. Arrows indicate the two primary body axes.
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reporter cells, representing a TCF activity-reporting fluores-
cent reporter assay (see Supporting information for details).
Confocal imaging of spheroids was performed 24 h or 48 h af-
ter their fusion, and the activation of TCF activity evoked by
mCherry-Wnt3a-secreting cells is evident (Fig. 3b). The
strongest TOP-GFP reporter activation is detected in cells
that are in direct contact with the mCherry-Wnt-3a-express-
ing cells (see arrows in Fig. 3b, 24 h); however, distinct activa-
tion of TOP-GFP is observed in all spheroid cells, including
those located several cell diameters away from mCherry-
Wnt-3a-expressing cells. Background activation of fluores-
cence in TOP-GFP spheroids is low at the 24-h time point,
and fluorescence levels are also similar after their fusion with
control spheroids prepared from LacZ-transfected cells (Fig.
3b, 24 h), which confirms specific and mCherry-Wnt-3a-de-
pendent activation. At the 48-h time point, background
Figure 2. EVI-dependent eGFP-Wnt-3a secretion and association of eGFP-Wnt-3a with exosomes. a, Western blots of indicated proteins from medium
(secreted) and corresponding cell lysates from WT HEK293T cells or EVI knockout HEK293T cells (HEK293T EVI-KO2.9), transfected as indicated. Asterisks indi-
cate nonspecific bands. b, Western blot analysis of proteins from purified exosomes derived from HEK293 cells transfected as indicated with Wnt-3a, eGFP-
Wnt-3a, or a 1:1 combination of both. Exosomes were purified by ultracentrifugation (see Materials and methods for details). The exosome marker proteins
Alix and Syntenin are indicated. c, TCF reporter assay using either WT HEK293T cells or DFZD1,2,4,5,7,8 HEK293T cells transfected with FZD2, FLUC, RLUC in com-
bination with the control (pcDNA), Wnt-3a, or eGFP-Wnt-3a. Error bars represent means6 S.D. from 5 independent biological samples, represented as solid
dots. The experiment was performed 2 times with similar results.
eGFP-Wnt-3a selectively binds Frizzleds
8762 J. Biol. Chem. (2020) 295(26) 8759–8774
TOP-GFP reporter fluorescence increased only marginally in
the control spheroid fusions, whereas the fluorescence inten-
sity in TOP-GFP spheroids fused to mCherry-Wnt-3a-pro-
ducing spheroids increased substantially (Fig. 3, b and c).
These results indicate that fluorescently tagged Wnt-3a can
readily diffuse between the tightly packed cells in the sphe-
roids to signal at a distance.
eGFP-Wnt3a interaction with FZD-mCherry
Wnts bind to FZDs with some degree of promiscuity (9, 35),
likely because of the conserved nature of the two Wnt-FZD
interaction sites on the CRD (21, 22). To assess the relative
interaction of eGFP-Wnt-3a to FZDs on live cells, we generated
stable NCI-H1703 cell lines expressing moderate levels of
FZD1–10 C-terminally tagged with mCherry at the plasma
membrane (Fig. 4a and Fig. S3b). Cell lines with broadly similar
expression levels of FZD1,2,4,6,7,8,9 at the cell surface were
selected for imaging (Fig. 4a, top); however, suitable cell
lines for FZD3,5,10 could not be obtained. The application of
eGFP-Wnt-3a-containing CM resulted in a strong increase in
membrane-associated green fluorescence when FZDs were
expressed (Fig. 4a, middle). A low intensity of eGFP-Wnt-
3a fluorescence was associated with WT NCI-H1703 cells
(Fig. 4a, middle, second from left), presumably because of asso-
ciation with endogenous FZDs, LRP6, or other endogenously
Figure 3. Diffusion of mCherry-Wnt-3a within spheroids. a, TOPFLASH TCF reporter assay showing the comparative activities of mCherry-Wnt-3a and
eGFP-Wnt-3a when applied to HEK293 cells as L-cell conditioned medium (CM). Error bars represent6 S.D. from mean of 4 independent biological samples,
represented as solid dots. The experiment was performed 2 times with similar results. Western blot analysis of eGFP-Wnt-3a and mCherry-Wnt-3a proteins in
the CM is shown in the lower panel. b, HEK293T cell spheroid fusion assay for visualization of paracrine Wnt/b-catenin signaling. mCherry-Wnt-3a- or control
lacZ-transfected HEK293 cells were used to form spheroids, which were then combined with spheroids prepared from a stable TOP-GFP HEK293 reporter cell
line. Twenty-four or 48 h later, merged spheroids were imaged using laser scanning confocal microscopy for activation of Wnt/b-catenin signaling in the TOP-
GFP reporter cells (green cells). The two lower arrows mark mCherry-Wnt3a-producing cells flanking a highly activated TOP-GFP reporter cell (smaller upper
arrow). BF, bright-field image showing fused spheroids with the dashed line demarking the border between the Wnt secreting/control cells and the TOP-GFP
reporter cells (TOP). The presented images are representative of findings obtained from 3 independent experiments. c, Bar graph showing the relative fluores-
cent intensities measured in the TOP-GFP spheroids shown in b, calculated from at least 9 merged spheroids under each of the assays conditions. Error bars
represent means6 S.D. from 10 independent fluorescence intensity values, represented as solid dots. The fluorescence intensity of the 24-h control TOP-GFP
spheroids is set to 1.
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Figure 4. Association of eGFP-Wnt-3a with different FZDs. a, Laser scanning confocal microscopy images of living NCI-H1703 cells with stable integration
of the indicatedmouse FZD-mCherry gene, incubated for 3 h with eGFP-Wnt-3a conditionedmedium (CM) derived from L cells. b, Laser scanning confocal mi-
croscopy images of living DFZD1–10
GFP-free HEK293 cells transiently transfected with the indicated mouse FZD-mCherry gene and incubated for 1 h with eGFP-
Wnt-3a CM derived from L cells. A direct comparison of the fluorescent intensities between the two cell lines in a and b is provided in Fig. S3b. c, TOPFLASH
TCF reporter assay responses in DFZD1–10 HEK293 cells, showing the relative Wnt/b-catenin signaling activity of the indicated mouse FZDs as well as their
mCherry-tagged counterparts. Error bars represent 6 S.D. from means of 4 independent biological samples, represented as solid dots. The experiment was
performed 3 times with similar results.
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expressedWnt receptors.We also usedDFZD1–10 HEK293 (34)
as host cells for transient transfection of the FZD-mCherry con-
structs. For this particular assay, we removed residual GFP
expression from the parental cell lines using CRISPR/CAS9 to
ensure that the eGFP signal solely originates from the addition
of eGFP-Wnt-3a CM (Fig. S3a). A comparison of the relative
FZD1-mCherry expression levels between stable NCI-H1703
cells and transiently transfected DFZD1–10
GFP-Free HEK293
cells, as well as their ability to associate with eGFP-Wnt-3a, is
shown in Fig. S3b. The relative association of plasma mem-
brane-localized green fluorescence (eGFP-Wnt-3a) with red
fluorescence (mCherry-tagged FZDs) was interpreted as a rela-
tive measure of Wnt-FZD affinity. More variation in cell sur-
face expression levels of the different FZD-mCherry constructs
was observed in the DFZD1–10
GFP-free HEK293 cells than the
NCI-H1703 cell lines (Fig. 4b, top). Nevertheless, similar differ-
ences were seen for relative cell surface association of eGFP-
Wnt-3a in FZD-expressing cells, arguing for subtype selectivity
of Wnt-3a binding to full-length FZDs (Fig. 4b, middle). Based
on these imaging data, we approximate that eGFP-Wnt-3a
associates more with cells expressing either FZD1, FZD2, FZD4,
FZD5, or FZD7 and less with cells expressing FZD8 or FZD9
(Fig. 4, a and b). Very low specific association of eGFP-Wnt-3a
to FZD6-expressing cells was observed, which, similar to FZD3,
shows strong preference for theWnt/planar cell polarity signal-
ing system (39). It must be underlined that it is a challenge to
accurately quantify this association assay, given the differences
in total and surface receptor expression of the FZD subtypes
and limitations in distinguishing specific from unspecific bind-
ing, Thus, the relative binding of eGFP-Wnt-3a to different
FZDs was approximated by visual inspection. The addition of
mCherry to the C-terminal region of FZDs reduces, but does
not prevent, their ability to transduce Wnt-3a signals when
expressed in DFZD1–10 HEK293 cells (Fig. 4c). Interestingly,
FZD9 maintains a strongWnt-3a-induced signaling activity de-
spite displaying relatively weak Wnt-3a cell surface association
(Fig. 3, a and b) and displaying no significant activity in an ear-
lier study using FZD1,2,4,5,7,8 null HEK293 cells (35). Taken to-
gether, these cellular association experiments suggest that full-
length, soluble eGFP-Wnt-3a binds to a range of different full-
length FZDs that are expressed on the surface of living cells.
Nevertheless, this microscopic analysis provides merely an esti-
mation of the relative ability of Wnt-3a to associate with differ-
ent FZDs and cannot provide a thorough quantification of
binding affinities.
Quantification of eGFP-Wnt-3a binding to FZD4 in live cells
To more precisely quantify the binding of eGFP-Wnt-3a to
FZDs, we employed a recently established NanoBRET assay
(19, 40) that relies on an extracellularly localized Nanolucifer-
ase (Nluc) on Nluc-FZD as the resonance energy donor and
eGFP-Wnt-3a as the energy acceptor (Fig. 5a). We focused on
FZD4 because (i) it presented as an intermediate binder of the
eGFP-tagged Wnt-3a in the cellular assay shown in Fig. 4a, (ii)
it is a well-described Wnt-3a receptor for mediating Wnt/
b-catenin signaling (39), and (iii) it is well expressed on the cell
surface. Nluc-FZD4 was transiently overexpressed in DFZD1–10
HEK293 cells (34), and eGFP-Wnt-3a was applied to the cells
as conditioned medium. For NanoBRET binding assays, differ-
ent eGFP-Wnt-3a preparations were used, from transiently
transfected HEK293F suspension cells in defined serum-free
medium, either with or without coexpressed Afamin (1Afamin
and –Afamin, respectively), and from a stable L-cell line in nor-
mal serum-containing medium. The concentrations of eGFP-
Wnt-3a were determined using GFP ELISAs (Fig. S4a). eGFP-
Wnt-3a derived fromHEK293F suspension cells associated rel-
atively quickly (kon5 2.693 10
6 M21·min21 for1Afamin and
4.34 3 106 M21·min21 for 2Afamin) with Nluc-FZD4 and
reached saturation after about 100 min (Fig. 5b). These kinetic
binding assays provided Kd values of 3.41 nM and 1.79 nM for
the1Afamin and2Afamin preparations, respectively (Fig. 5b).
In contrast, eGFP-Wnt-3a derived from L cells did not reach
saturation even after 3 h of incubation, precluding an estima-
tion of binding affinity from these kinetic experiments (Fig.
S4b, upper graph).
The concentrations of eGFP-Wnt-3a used in the kinetic
experiments were adjusted to the highest concentration possi-
ble of eGFP-Wnt-3a2Afamin and to the dilution factors of the
assay format. Because of the lipophilicity ofWnts, high nonspe-
cific binding can compromise the selective FZD-dependent sig-
nal, even though the NanoBRET-based binding assay provides
an excellent signal-to-noise ratio. Therefore, we added Nluc-
FZD6 to our NanoBRET assessment of eGFP-Wnt-3a binding
to include a FZD that showed weak eGFP-Wnt-3a binding in
the cellular association assay. In agreement with the lack of cell
surface association to FZD6-mCherry-expressing cells (Fig. 4, a
and b), no significant NanoBRET signal was detected between
eGFP-Wnt-3a- and Nluc-FZD6-expressing cells (Fig. S4c).
Likewise, the FZD-related Smoothened (SMO), which was
used as a negative control because it does not associate with
Wnt, failed to show significant binding in these assays (Fig.
S4c). Cell surface expression of all Nluc-tagged FZD/SMO con-
structs was quantified using the detection of an N-terminal
Nluc tag in an ELISA format (Fig. S4d).
To define a more precise binding affinity ofWnt-3a to FZD4,
we incubated Nluc-FZD4-expressing cells with increasing con-
centrations of HEK293F cell- or L-cell-derived eGFP-Wnt-3a
for 2 h (Fig. 5c and Fig. S4b). The raw BRET ratio representing
eGFP-Wnt-3a to FZD4 binding increased in a concentration-
dependent manner. For the HEK293F-derived eGFP-Wnt-3a,
the affinity values were calculated to be the following: pKd 5
8.436 0.06 (3.68 nM) for the1Afamin preparation and pKd 5
8.64 6 0.02 (2.31 nM) for the 2Afamin preparations (Fig. 5c).
Similar to the kinetic experiments, the L-cell-derived eGFP-
Wnt-3a binding did not reach saturation following 2 h of incu-
bation, and the affinity can only be estimated (pKd 5 8.48 6
0.05; 3.32 nM) (Fig. S4b, lower). Affinity values were determined
from the normalized curves shown in Fig. 5d and Fig. S4b.
Additionally, we performed NanoBiT binding assays (Fig. S4e)
using HiBiT-tagged FZD4 and FZD6 to demonstrate that the
lack of detectable eGFP-Wnt-3a binding to Nluc-FZD6 is not a
consequence of steric hindrance caused by the Nluc tag (Fig.
S4f). Finally, to exclude that agonist-induced receptor internaliza-
tion compromises the assessments of ligand binding parameters,
we performed bystander BRET-based live-cell internalization
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assays. Whereas b2-adrenergic receptors (b2AR-Nluc) expressed
in DFZD1–10 HEK293 cells and stimulated with 10 mM isoprena-
line were readily internalized, FZD4-Nluc did not internalize in
response to 26.7 nM (1.0 mg/ml; Fig. S4g) of commercially avail-
able untagged humanWnt-3a.
Discussion
Generally, FZDs show overlapping expression in tissues and
cells (41), whereas sources of Wnt expression are more spatio-
temporally restricted (41, 42), meaning Wnts are faced with
considerable complexity regarding the engagement of FZDs to
transduceWnt signals. It remains unclear how cells achieve se-
lectivity for particular Wnt-FZD pairs and what the underlying
biochemical and biophysical properties are that determine re-
ceptor selectivity and pathway specification. Although corecep-
tors clearly afford some degree of specificity within the Wnt
signaling network (34), much effort is focused on identifying
the degree of specificity/redundancy for different Wnt-FZD
combinations and to quantify their relative binding affinities.
Recent work has provided a clearer overview of which Wnts
functionally pair with which FZDs (9, 35), and although speci-
ficity indeed exists, a significant degree of promiscuity is appa-
rent, in particular for Wnt-3a (9, 35). The availability of a solu-
ble GFP-tagged version of Wnt-3a that functions similarly to
WT Wnt-3a, together with new methodologies, such as the
NanoBRET binding assay used here, allows quantification of
Wnt-FZD binding in a precise, direct, and pharmacologically
sound manner. As an initial step in this direction, we have
focused on the precise quantification of the binding between
Wnt-3a and FZD4. Employing real-time analysis on living cells,
we have calculated the binding affinity of solubleWnt-3a to cell
surface-localized full-length FZD4 to be in the low-nanomolar
Figure 5. eGFP-Wnt-3a binding to Nluc-FZD4. a, Schematic illustration of the NanoBRET setup to detect eGFP-Wnt-3a binding to Nluc-FZD-tagged recep-
tors. b, Association kinetics of the HEK293F suspension cell-derived eGFP-Wnt-3a to Nluc-FZD4 were determined by the detection of NanoBRET in transiently
overexpressing living DFZD1–10 HEK293 cells over time. eGFP-Wnt-3a was produced either with (left) or without (right) cellular coexpression of Afamin. Nano-
BRET was sampled once per 60 s for 180 min. Data points are presented as means6 S.D. (1Afamin) or means6 S.E. (2Afamin) from n = 3 individual experi-
ments, fitting a one-phase association model. The kobs values from the individual eGFP-Wnt-3a association curves were plotted over eGFP-Wnt-3a
concentration. c, Saturation curves are presented as sigmoidal curves with logarithmic eGFP-Wnt-3a concentrations (left panel for eGFP-Wnt-3a1 Afamin and
the right panel for eGFP-Wnt-3a2Afamin). Graphs present raw NanoBRET values obtained following 2-h ligand exposure to living DFZD1–10 HEK293 cells tran-
siently overexpressing Nluc-FZD4. d, Raw BRET ratio values for eGFP-Wnt-3a binding from cwere normalized to 0 and 100% to emphasize the difference in af-
finity. Data points are presented asmean6 S.E. from n = 3 individual experiments.
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range (2–3 nM) for the HEK293F cell-derived CM. Previous in
vitro studies relying solely on the CRD of FZDs reported some-
what lower binding affinities for Wnt-3a-FZD4 (5.4 nM) (9).
Thus, our work highlights the importance of studying ligand-
receptor interactions under conditions that resemble native
cellular environments, where contributions from potential
cofactors/coreceptors, the glycocalyx, andmembrane dynamics
likely play an important role. Future efforts to study all Wnt-
3a-FZD pairs under these native conditions, as well as addi-
tional Wnt-FZD pairs, will be a valuable contribution to our
understanding ofWnt signaling selectivity.
The presented eGFP-Wnt-3a construct encodes a stable
fusion protein that is secreted from cells in an EVI-dependent
manner and transduces Wnt/b-catenin signaling in a variety of
different biological contexts. Interestingly, there are some con-
text-dependent differences in the relative activity of eGFP-
Wnt-3a. There is little difference in the activity of WTWnt-3a
and eGFP-Wnt-3a when assayed in NCI-H1703 cells; however,
there is an 80% reduction in activity using HEK293 cells. The
reason for this discrepancy is unclear but likely reflects differ-
ences in gene expression profiles between the two cell lines.
Indeed, when FZDs or LRP6 is overexpressed in HEK293 cells,
the difference in activity betweenWTWnt-3a and eGFP-Wnt-
3a narrows significantly (Fig. 2c and Fig. S1c). Furthermore,
TOPFLASH reporters are highly tuned cellular readouts for
Wnt/b-catenin signaling, and when additional, arguably more
physiologically relevant, readouts are used, such as endogenous
LRP6 phosphorylation, Wnt-3a and eGFP-Wnt-3a display sim-
ilar activities. Likewise, the equal ability of Wnt-3a and eGFP-
Wnt-3a to promote axis duplication in Xenopus laevis embryos
argues that fluorescent tagging of Wnt-3a at the N terminus
does not appear to significantly compromise signaling activity
within physiologically relevant contexts. We conclude that
eGFP-Wnt-3a can be employed as a reliable tool to study Wnt
signaling andWnt-receptor interactions.
Structural studies describe the molecular mechanisms
underlying the formation of Wnt-FZD complexes (21, 22) and
allow some predictions to be made concerning Wnt-FZD-
LRP6 ternary complex formation as well as oligomerization
into higher-order structures (21, 22, 43–46), all of which should
be relevant for the signaling activity and specificity of different
Wnts. For binding of humanWnt-3 to the CRD of mouse FZD8
(21), which is of the most relevance to our study, some freedom
of movement exists for Wnt tethered to the CRD by the “index
finger-thumb clamping” mechanism. This positioning toler-
ance, or wobble, should allowWnts some degree of flexibility in
presenting their coreceptor interaction sites (43) and may help
explain why, upon fusion of a 25-kDa GFP accessory protein,
Wnt-3a retains its functional properties.
A soluble Flag-GFP-Wnt-3a fusion protein was recently
shown to form 150-kDa complexes of GFP-Wnt-3a:Afamin
and, to a lesser degree, higher-molecular-weight complexes,
including a 200-kDa homotrimeric assembly of GFP-Wnt-3a
(18). Considering the similarity of our eGFP-Wnt-3a, we
assume a similar mixture of Afamin-bound and homomeric
GFP-Wnt-3a complexes is present in our CM preparations. In
apparent agreement with the findings that Wnt-3a can travel
freely within the extracellular milieu (18), we also show that
mCherry-Wnt-3a diffuses away from its cellular source and
reaching cells within 3D spheroids that are located many cell
diameters. In line with previous work (28), the coexpression
of Afamin with eGFP-Wnt-3a in HEK293F suspension cells
allows higher concentrations of eGFP-Wnt-3a to be obtained.
Importantly, our NanoBRET data reveal different Wnt-3a-
FZD4 binding characteristics for the two HEK293F cell CM
preparations used (6Afamin), and it is tempting to speculate
that differentially packaged Wnt and/or Wnt-Afamin com-
plexes engage differently with FZDs, thereby altering their sig-
naling specificity. Despite harboring concentrations of eGFP-
Wnt-3a similar to those of HEK293F cell (2Afamin) prepara-
tions, L-cell-derived eGFP-Wnt-3a does not generate reliable
binding assay data because of a lack of saturation binding. The
L-cell-derived CM preparations should contain eGFP-Wnt-3a
bound to Afamin (18, 28), because Afamin is present in the cul-
ture medium of L cells during production/secretion (because
of its presence in serum). For HEK293F suspension cells
(2Afamin), there is no serum present during production/secre-
tion processes. However, serum is added at the final CM proc-
essing step to help stabilize Wnt-3a, so traces of Afamin will be
present during the binding assays. Nevertheless, when Afamin
is coexpressed with eGFP-Wnt-3a in HEK293F cells during the
production/secretion process (1Afamin preparation), the bind-
ing affinity and kinetics are noticeably reduced compared with
those of the 2Afamin preparation. It is presently unclear
whether Afamin can associate with Wnt proteins during the
secretion process in coexpressing cells; however, it is conceiva-
ble that this influences the formation of Wnt complexes com-
pared with that of cells that release “naked” Wnt into Afamin-
containing extracellular environments. It will be interesting to
study whether the formation of specificWnt/Wnt-Afamin com-
plexes guides distinct export routes, such as secretion, exosome
association, or filipodial delivery to neighboring cells (47), and
how packaging and carrier protein association affects FZD bind-
ing characteristics. Our paracrine signaling system, using sphe-
roids of TOP-GFP reporter cells together with spheroids secret-
ing fluorescently labeled Wnt proteins, should allow us to
address some of these topics in more detail in the future.
The recently developed NanoBRET assay provides a high
degree of selectivity because of the detection of specific energy
transfer rather than measuring solely fluorescence associating
with the membrane. This allowed the previous assessment of
the binding of lipophilic BODIPY-cyclopamine to SMO (40)
and FZD6 (48). Similarly, we exploit the assay’s excellent signal-
to-noise ratio here for the quantification of Wnt-FZD interac-
tion. Whereas the assay allows kinetic analysis of ligand-recep-
tor association, ligand binding follows very slow kinetics
depending on the Wnt preparation. Irrespective of the Wnt
preparation, the slow on-rate may be caused by predominant
Wnt interactions with the extracellular matrix composed of, e.
g. heparan sulfate proteoglycan such as glypicans (49). The
apparent affinity of eGFP-Wnt-3a to full-length FZD4 in the
low-nanomolar range, compared with previous data reporting
affinities of Wnts for isolated CRDs, argues that the seven-
transmembrane-spanning core contributes to ligand binding,
even though the molecular details remain unresolved. Further-
more, it should also be pointed out that this binding assay does
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not provide any information on the stoichiometry of the
ligand-receptor complex.
Our understanding of Wnt signaling has advanced consider-
ably in the 25 years since the discovery of FZD (50) as the prin-
cipal class of Wnt receptors. Some of the most notable mile-
stones since this seminal discovery includes the discovery of
Dickkopf (DKK) proteins as general inhibitors of Wnt/b-cate-
nin (51), the discovery of LRP5/6 as Wnt/b-catenin pathway
coreceptors (52–54), the discovery that Wnts undergo highly
regulated secretion processes (55, 56), and the solving of the
structural basis of Wnt-FZD binding (22). Throughout this pe-
riod, however, there has been much difficulty associated with
working with lipidatedWnt proteins, which has hampered pro-
gress in our understanding of ligand-receptor interaction speci-
ficity. The recent advances in generating fluorescently tagged
versions of Wnt-3a proteins that retain functional properties
(this work and a recent study [18]) provide an important new
impetus in this direction. Here, we provide a clear example of
the advances that can now be made with respect to unraveling




Mouse pCS21eGFP-Wnt-3a was generated by inserting the
NheI and XhoI restriction sites directly upstream of the Wnt-
3a signal peptide. These restriction sites then were used to
insert the eGFPORF followed by a short linker (GGSGLE). For
the cell line stably expressing eGFP-Wnt-3a, the ORF of the
eGFP-Wnt-3a fusion was inserted between the NheI and NotI
restriction sites of the pEF1a-IRES-Neo plasmid (a gift from
Thomas Zwaka, Addgene, plasmid 28019) to create pEF1a-
eGFP-Wnt-3a-IRES-Neo. pCMV3-His-hAfamin was obtained
from Sino Biological (HG13231-CH).
Mouse pmCherry-FZD4-mCherry was constructed by replac-
ing the eGFP ORF of pEGFP-N2-FZD4-eGFP (Addgene, plas-
mid 42197) with mCherry ORF amplified from pCS21LRP6-
mCherry2 using the NEBuilder HiFi DNA assembly kit (New
England Biolabs, E2621S). Mouse pmCherry-FZD1,2,5,6,7,8,9,10-
mCherry constructs were prepared by replacing the FZD4 ORF
of pmCherry-mFZD4-mCherry with other FZDORFs amplified
from PRK5-FZD1 (Addgene, 42253), PRK5-FZD2 (Addgene,
42254), PRK5-FZD5-1D4 (Addgene, 42267), PRK5-FZD6
(Addgene, 42258), PRK5-FZD7 (Addgene, 42259), PRK5-FZD8
(Addgene, 42260), PRK5-FZD9 (Addgene, 42261), and PRK5-
FZD10 (Addgene, 42262), respectively. The pEF1a-IRES-Puro
plasmid for generating stably expressing FZD cell lines was
assembled using NEBuilder by combining the NotI/ClaI linear-
ized back bone of pEF1a-IRES-NEO4 (Addgene, plasmid
28019) with the IRES from pEF1a-IRES-NEO and the Puro
ORF fromOct4-eGFP-PGK-PURO5 (Addgene, plasmid 31937).
FZD1,2,4,6,7,8,9,10-mCherry ORFs then were excised from the
corresponding pmCherry-FZD-mCherry plasmids and cloned
in pEF1a-IRES-Puro using XhoI and NotI restriction sites. 7-
TGP6 (Addgene, 24305) was used to generate fluorescent
(7xTCF-GFP) reporter cells using a 3rd-generation lentiviral
packaging system. pVSV-G, pRSV-Rev, and pMDLg/pRRE were
gifts from LeonelMunoz.
Nluc-A3 was from Stephen Hill (University of Nottingham,
UK) (19), and it was used as a template for cloning. The human
FZD4 sequence (57) without its signal peptide (aa 1–36) was
subcloned in-frame into an empty N-terminally tagged Nluc
vector containing 5-HT3A signal peptide using BamHI and
XbaI restriction sites with the following primers: 59-GAC GGA
TCC TTC GGG GAC GAG GAA GAG CGG-39 (forward) and
59-GTC TCT AGA TAC CAC AGT CTC ACT GCC TTT-39
(reverse). To generate HiBiT-FZD4 and HiBiT-FZD6 con-
structs, Nluc sequences in Nluc-FZD4 and Nluc-FZD6 (48)
were replaced with HiBiT sequences (nucleotides sequence, 59-
GTG AGCGGCTGGCGGCTG TTCAAG AAGATTAGC-
39; amino acids sequence, VSGWRLFKKIS). The constructs
were validated by sequencing (Eurofins GATC, Konstanz, Ger-
many). For Nluc-FZD4, live-cell ELISA was used to quantify
surface expression of the protein on cells. Nluc-SMO (coding
for mouse Smoothened) and FZD4-Nluc were generated and
characterized as described previously (37, 40). The synthetic
construct anchoring two HaloTags, separated by a repetitive
rigid linker, to the plasma membrane and C-terminally Nluc-
tagged b2AR (b2AR-Nluc) were kindly provided by Jan Möller
and Martin J. Lohse (Max-Delbrueck Center for Molecular
Medicine, Berlin, Germany).
Cell culture
Human embryonic kidney 293T (HEK293T) cells (DSMZ
ACC-635), DFZD1–10 HEK293 cells (34) mouse fibroblast
L-cells (ATCC®CRL-2648TM), stably expressingWnt-3a L cells
(ATCC® CRL-2647TM), and stably expressing eGFP-Wnt-3a L
cells (clone SF75, generated in this project) were cultured in
Dulbecco’s modified Eagle medium (Thermo Fisher, Waltham,
MA) supplemented with 10% fetal bovine serum (Thermo
Fisher) and 1% penicillin-streptomycin (P/S; Gibco; Thermo
Fisher). NCI-H1703 human lung carcinoma cells (ATCC®
CRL-5889TM) and NCI-H1703 cell lines with stable integration
of mouse FZD1,2,4,6,7,8,9-mCherry (generated in this project)
were cultured in Roswell Park Memorial Institute (RPMI) 1640
medium (Thermo Fisher) supplemented with 10% FBS and 1
mM sodium pyruvate (Thermo Fisher). All cell lines were main-
tained at 37 °C and 5% CO2. Expi293F
TM suspension cells
(Thermo Fisher, A14527) were cultured in Expi293TM expres-
sion medium (Thermo Fisher) at 37 °C and 8% CO2 with 125
rpm orbital shaking in a New Brunswick S41i CO2 shaking in-
cubator (Eppendorf). Cell densities and viability were deter-
mined using a Countess II automated cell counter (Life
Technologies).
Preparation of wnt-3a and eGFP-Wnt-3a CM
For L-cell CM,Wnt-3a CMwas prepared frommouse L cells
stably transfected with mouse Wnt-3a (ATCC® CRL-2647TM).
eGFP-Wnt-3a CMwas prepared from a stable L-cell line gener-
ated from mouse L cells (ATCC® CRL-2648TM) stably trans-
fected with eGFP-Wnt-3a (clone SF75). Control CM was pre-
pared from nontransfected L cells (ATCC® CRL-2648TM).
Cells weremaintained at 37 °C and 5%CO2.
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For the1Afamin HEK293FTMCM, suspension cells growing
in Expi293TM expression medium (60 ml, 2.5 3 106 cells/ml)
were cotransfected with 10 mg of either pCS21-Wnt-3a or
pCS21-eGFP-Wnt-3a together with 50 mg of pCMV-His-Afa-
min plasmid using ScreenFect® UP-293 (ScreenFect GmbH)
according to the manufacturer’s instructions. For the2Afamin
HEK293FTM CM, 40 mg of pCS21-eGFP-Wnt-3a together with
20 mg of pCMV plasmid. Wnt-3a and eGFP-Wnt-3a CM were
collected 96 h posttransfection. The corresponding control CM
was generated from cells transfected with pCMV plasmid.
For downstream experiments, the serum-containing CM
samples from L cells were first centrifuged at 130 relative cen-
trifugal force for 10 min to remove cells and then at 3,000 rela-
tive centrifugal force for 30min to remove any remaining cellu-
lar debris and insoluble material. This “raw” CM then was
concentrated 13-fold using Vivaspin turbo 15 and 30,000-mo-
lecular-weight-cutoff ultra filters (Satorius AG, Göttingen, Ger-
many) and exchanged to the desired cell culture medium using
Sephadex G-25 PD10 desalting columns (GE Healthcare
Bio-Science, Freiburg, Germany). Serum-free CM from HEK
293FTM suspension cells were prepared as for L-cell CM but
concentrated only 5-fold using Vivaspin turbo 15 and 30,000-
molecular-weight-cutoff ultra filters. The final concentration
and integrity of eGFP-Wnt-3a in the CM samples were deter-
mined using ELISA (GFP ELISA® kit, Abcam, ab171581).
WB analysis
For Western blot (WB) analysis of Wnt-3a and eGFP-Wnt-
3a, proteins were first purified from serum-containing CM
using Cibacron blue 3G coupled to Sepharose 6 Fast Flow
(Blue-Sepharose 6 Fast Flow, GE Healthcare). Conditioned me-
dium was supplemented with Triton X-100 to a final concen-
tration of 1%. Blue-Sepharose beads were washed three times
with Blue-Sepharose buffer (BS-buffer) (150 mM KCl, 50 mM
Tris-HCl, pH 7.5, 1% Triton X-100) containing Complete®
protease inhibitormixture (Roche, Basel, Switzerland).Washed
beads were added to the samples and rotated overnight at 4 °C.
The next day, beads were washed three times in BS-buffer and
proteins eluted by heating in Laemmli sample buffer.
For Western blot analysis of endogenous LRP6, HEK293T as
well as NCI-H1703 cells cultured in 24-well plates were treated
with 150 ml control, Wnt-3a, or eGFP-Wnt-3a CM for 90 or
120 min. Cells were lysed in 1% Triton lysis buffer (1% Triton
X-100, 50 mM Tris-HCl [pH 7.0], 150 mM NaCl, 25 mM NaF, 5
mM Na3VO4, 0,1% NP-40, 1 mM EDTA) containing Complete
®
protease inhibitor. After 15 min of incubation on ice, cell
lysates were centrifuged at 10,000 3 g at 4 °C for 10 min, and
lysates were supplemented with Laemmli sample buffer and
heat denatured.
Samples were separated by SDS-PAGE before transfer to a
PVDF membrane using a Bio-Rad Transblot-Turbo system
(Bio-Rad). Membranes were blocked at room temperature for 1
h in 5% BSA–TBST blocking buffer (5% BSA, 137mMNaCl, 2.7
mM KCl, 19 mM Tris base [pH 7.4], 0.1% Tween-20) and trans-
ferred to a BioLane HTI automatedWestern blotting processor
for antibody incubation and washing steps. The following anti-
bodies were used: anti-Wnt-3a (ab28472, 1:1000, Abcam), anti-
LRP6 ([1C10], 1:1,000, Abcam), anti-phospho-LRP6 (Sp1490,
1:1,000, Cell Signaling), anti-GFP (ab1828, 1:2,000, Abcam),
anti-Vinculin (E1E9V, 1:1,000, Cell Signaling), and HRP-conju-
gated anti-rabbit or anti-mouse secondary antibodies (Dako).
For semiquantitative detection of protein bands, the mem-
branes were incubated with ECL Prime (GE-Healthcare Bio-
science) and imaged using a ChemiDocTM touch imaging sys-
tem (Bio-Rad).
For Western blots shown in Fig. 2a, Blue-Sepharose pull-
down ofWnt-3a was performed as described previously (58). In
brief, 1.0 3 106 HEK293T and HEK293T EVI KO2.9 (58) cells
were seeded into 6-well plates. Twenty-four hours later, cells
were transfected with 500 ng pcDNA, Wnt-3a, or eGFP-Wnt-
3a and 1.5 ml TransIT (Mirus, VWR) per well according to the
manufacturer’s instructions. Twenty-four hours after transfec-
tion, supernatants were recovered and centrifuged at 2,0003 g
for 10 min to remove cell debris. Remaining cells were har-
vested and lysed in BS-buffer (150 mM KCl, 50 mM Tris-HCl,
pH 7.5, 1% [v/v] Triton X-100, protease inhibitors) and 63
Laemmli buffer. Supernatants were supplemented with Triton
X-100 to a final concentration of 1% (v/v), and prewashed Blue-
Sepharose 6 Fast Flow (17-0948-01, GE Healthcare) was added.
After overnight rotation at 4 °C, samples were washed several
times with BS buffer and centrifuged at 2,700 3 g for 5 min at
4 °C. The beads were resuspended in 23 Laemmli buffer.
Supernatants and cell lysates were incubated at 96 °C for
5 min and then subjected to SDS gel electrophoresis and
Western blot analysis. The following antibodies were used:
anti-EVI antibody (1:500, monoclonal mouse, clone YJ5,
BioLegend, 655902), anti-HSC70 (1:1,000, mouse, Santa Cruz,
sc-7298), anti-Wnt-3A (1:1,000, rabbit, Abcam, ab28472), and
secondary HRP-coupled goat anti-mouse (1:10,000, Jackson
ImmunoResearch) and goat anti-rabbit (1:10,000, Jackson
ImmunoResearch).
Confocal laser scanning microscopy
For the microscopy analysis of eGFP-Wnt-3a binding to
Frizzled receptors, DFZD1–10
GFP-Free HEK293 cells were trans-
fected with 5 ng of pCherry-mFzd-mCherry and 220 ng empty
pCS21 in m-Slide 8-well chambers (Ibidi, catalog no. 80826),
and, as a control, DFZD1–10
GFP-Free HEK293 cells were trans-
fected with 225 ng empty pCS21. Twenty-four hours posttrans-
fection, control or eGFP-Wnt-3a CM was added to cells and
incubated for 1 h. For microscopy, cell medium was exchanged
for Gibco FluoroBrite DMEM (Thermo Fisher, Waltham, MA)
supplemented with 10% FBS, 2 mM L-glutamine (Gibco,
Thermo Fischer), and 1% P/S. For analysis of eGFP-Wnt-3a
binding to WT NCI-H1703 cells or the NCI-H1703 cell lines
with stable integration of themFZD-mCherry genes, cells were
seeded in m-Slide 8-well chambers so that they were 80% con-
fluent for microscopy after 2 days. Prior to imaging, cells were
treated with control or eGFP-Wnt-3a CM for 3 h. For micros-
copy, the cell culture medium was replaced with phenol red-
free RPMI mixed 1:1 with FluoroBrite, supplemented with 10%
FBS, 1 mM sodium pyruvate, 2 mM L-glutamine, and 1% P/S.
Image acquisition was performed using a Zeiss LSM 800
microscope (Zeiss, Jena, Germany) fitted with a 633/1.4 oil
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differential interference contrast (UV) VIS-IR Plan-Apochro-
mat objective (Zeiss, Jena, Germany) and a GaAsP-PMT detec-
tor. The red mCherry and green eGFP fluorescent proteins
were excited at 561 nm and 488 nm, respectively, and their re-
spective emissions were captured in the range of 570–700 nm
and 400–576 nm, employing the standard filter sets where
appropriate. Images were analyzed using Fiji (59).
CRISPR/Cas9 knockout
DFZD1–10 HEK293T cells were generated as described previ-
ously using pSPCas9(BB)-2A-GFP (PX458) (34). However,
these cells display significant background cytosolic GFP fluo-
rescence that interferes with imaging, so we removed the ran-
domly integrated GFP from the genome of these cells using
CRISPR/Cas9 editing. We used the crispor online tool (crispor.
trefor.net) (60) to identify two 20-bp protospacers, one at the 59
start (59-GCTCCTCGCCCTTGCTCACT-39, gRNA51) and
one in the middle (59-GCAACTACAAGACCCGCGCCG-39,
gRNA449) of theGFPORF. These were used simultaneously to
remove ;335 bp at the 59 end of the GFP ORF. Each of the
complementary DNA fragments was designed with the neces-
sary overhangs, annealed, and ligated into the BbsI restriction
site of the pX330-U6-Chimeric_BB-CBh-hSpCas9 (D10) vector
(61), generating two plasmids encoding a single guide RNA,
each harboring a GFP-specific 20-bp protospacer under the
control of a U6 RNA polymerase III promoter.
DFZD1–10 HEK293T cells cultured in 6-well plates were
transfected with 1 mg pX330-U6-gRNA51-CBh-hSpCas9 (D10)
and 1 mg X330-U6-gRNA449-CBh-hSpCas9 (D10) using
ScreenFect® A (ScreenFect GmbH) according to the manufac-
turer’s 1-step protocol. Twenty-four hours posttransfection, the
medium was exchanged. Forty-eight hours posttransfection, single
cells were transferred to 96-well plates using limited dilutions to
amplify clonal lines. Cells were screened using fluorescencemicros-
copy for GFP-negative clonal lines. The new DFZD1–10 HEK293T
clonal GFP knockout line was named DFZD1–10
GFP-Free HEK293T
to differentiate it from the parental DFZD1–10 HEK293T cells that
express cytosolicGFP (34).
Xenopus laevis axis duplication assays
In vitro fertilization, embryo culture, preparation of mRNA,
and microinjection were carried out as described (62). mRNA
was prepared using the InvitrogenTM mMESSAGE mMACHI-
NETM SP6 transcription kit according to the manufacturer’s
protocol. Xenopus laevis embryos were injected equatorially
with 2.5 pg of either Wnt-3a, eGFP-Wnt-3a, or lacZ mRNA
into each of the two ventral blastomeres at the four-cell stage.
Embryos were left to develop at 18 °C until stage 28 for analysis.
TheXenopuswork has been approved by the state review board
of Baden-Wuerttemberg, Germany (license no. G-13/186 and
G-141/18) and performed according to federal and institutional
guidelines.
Generation of cell lines stably expressing eGFP-Wnt-3A and
FZD-mCherry
L-cells were transfected with 2 mg pEF1a-eGFP-Wnt3a-IRES-
Neo, and NCI-H1703 cells were transfected with 2 mg pEF1a-
FZD-mCherry-IRES-Neo in 6-well plates using ScreenFect® A
(ScreenFect GmbH) according to the manufacturer’s 1-step
protocol. Twenty-four hours posttransfection, themediumwas
exchanged, and 48 h posttransfection one-tenth of the cells
were transferred to 10-cm2 dishes and cultured in their respec-
tive cell culture medium supplemented with 1.2 mg/ml (L cells)
or 700 mg/ml (NCI-H1703) G418 (Sigma-Aldrich). Selection
was performed for 12 days. Clonal lines were obtained by lim-
ited dilutions in 96-well plates, and, for analysis in this study,
cell lines expressing similar levels of FZD-mCherry on the
plasmamembrane were selected bymicroscopy screening.
Generation of 7-TGP fluorescent TOP-GFP reporter cell line
For virus packaging, 10-cm dishes of HEK 293T cells at 70%
confluence were transfected with 10 mg of 7-TGP, 2.8 mg of
pVSV-G, 2.5 mg of pRSV-Rev, and 5 mg pMDLg/pRRE using
ScreenFect® A (ScreenFect GmbH) by following the manufac-
turer’s instructions. Twenty-four hours posttransfection, cell
culture supernatants were collected in a 10-ml syringe, filtered
through a 0.45-mm filter, and directly added toHEK293T target
cells. Target cells were incubated with virus-containing me-
dium overnight. A second round of lentivirus harvest/lentivirus
infection was performed as described above on the same HEK
293T target cells. HEK 293T target cells then were allowed to
recover in fresh DMEM for 24 h before selection in puromycin-
containing medium for 72 h. Surviving cells were seeded at 0.5
cells/well in 5 96-well plates for single-colony amplification. Af-
ter 2 weeks, single colonies were picked and split between two
96-well plates on separate plates and treated overnight with ei-
ther control or Wnt-3a CM, and clones with the best Wnt-
induced signal and lowest background were selected using fluo-
rescencemicroscopy.
TOPFLASH reporter assays
To test the biological activity of eGFP-Wnt-3a, 6 3 104
HEK293T or 4.5 3 104 NCI-H1703 cells cultured in 96-well
plates were transfected with 20 ng TCF firefly luciferase (TOP-
FLASH), 2 ng CMV Renilla luciferase, and 78 ng LacZ using
ScreenFect®A according to themanufacturer’s 1-step protocol
(ScreenFect GmbH). Twenty-four hours posttransfection, me-
dium was replaced by control, Wnt-3a, or eGFP-Wnt-3a CM,
and cells were incubated for another 24 h before harvesting cell
lysates.
For the TOPFLASH luciferase assay shown in Fig. 2c, 4.0 3
104 HEK293T and HEK293T FZD knockout cells (HEK293T
DFZD1,2,4,5,7,8 clone1 [35]) were seeded per well in 96-well
plates. Twenty-four hours after seeding, cells were transfected with
25 ng TCF4/Wnt-Firefly luciferase (63), 5 ng CMV-Renilla lucifer-
ase, with or without 2 ng pCMV-XL4 FZD2 (Origene, SC127603),
2 ng pcDNA, Wnt-3a, or eGFP-Wnt-3a, and 0.1 ml TransIT-LT1
(Mirus, VWR) per well according to the manufacturer’s instruc-
tions. Dual-luciferase readout was performed using the Mithras
LB940 plate reader (Berthold Technologies) 24 h later. TCF4-
FLUCvalues were normalized to theCMV-RLUC values.
To test the biological activity of the different FZDs and
their mCherry-tagged counterparts, 63 104 DFZD1–10
GFP-free
HEK293 cells in 96-well plates were transfected with
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TOPFLASH/Renilla reporter plasmids (20/2 ng), 0.2 ng of ei-
ther pRK5-FZD or pCherry-FZD-mCherry, and 77 ng lacZ.
Twenty-four hours posttransfection, culture medium was
replaced with either control or Wnt-3a CM, and cells were
incubated for another 24 h before harvesting cell lysates for
luciferase assays. For the luciferase assays, cells from 96-well
plates were harvested in 43 ml passive lysis buffer (Promega,
Mannheim, Germany) and processed according to the manu-
facturer’s protocol. TOPFLASH luciferase values were nor-
malized to control Renilla luciferase values. All error bars
shown are standard deviations from the mean (6S.D.) of the
indicated number of independent biological samples within
an experiment, and all experiments were performed at least 3
times, unless indicated otherwise in the figure legends. Data
were analyzed using GraphPad Prism 8.
Exosome purification and analysis
HEK293T cells were maintained in DMEM (Gibco) supple-
mented with 10% fetal calf serum (Biochrom) at 37 °C in a
humidified atmosphere with 5% CO2. Cells were transiently
transfected with plasmids using Screenfect® A (Screenfect
GmbH) according to the manufacturer’s instructions. Extracel-
lular vesicles were purified by differential centrifugation as
described previously (64, 65). In short, supernatants from
mammalian cells were subjected to sequential centrifugation
steps of 7503 g, 1,5003 g, and 14,0003 g before pelleting exo-
somes at 100,000 3 g in a Beckman Coulter TLA 100.3 rotor.
The exosome pellets were washed at 100,000 3 g for 1 h. The
supernatant was discarded, and exosomes were dissolved in
1/100 their original volume in 13 PBS. Isolation of exosomes
by magnetic-activated cell sorting involved positive selection
using MicroBeads recognizing the tetraspanin protein CD9,
CD63, or CD81. The immunobead isolation was performed
using the exosome isolation kit Pan-130-110-912 according to
the manufacturer’s protocol (Miltenyi Biotec GmbH). First, EVs
are magnetically labeled during a short incubation period and
then loaded onto a m column, which is placed in the magnetic
field of a mMACSTM separator. The magnetically labeled EVs are
retained within the column. After removing the column from the
magnetic field, the intact EVs are collected by elution with isola-
tion buffer and lysed with radioimmunoprecipitation assay
buffer. The exosome samples were further analyzed by Western
blotting. Antibodies were used against Wnt-3a, 1:500 (WB; rab-
bit, Abcam), Syntenin, 1:2,000 (WB; rabbit, Abcam), and Alix,
1:2,000 (WB;mouse, Santa Cruz Biotechnology, 1A12).
3D spheroid fusion assays
Superhydrophobic-superhydrophilic patterned glass slides
(7.5 by 2.5 cm) were obtained fromAquarray GmbH, Germany.
Each slide has three arrays, and each array has 14 by 14 hydro-
philic spots (1 mm by 1 mm). Two hundred cells (200 nl of 13
106 cells/ml) from either the mCherry-Wnt-3a-expressing,
control LacZ-expressing, or TOP-GFP reporter lines were
seeded into individual spots on the patterned slides in defined
patterns using an I-DOT dispenser (Dispendix GmbH, Ger-
many). After culturing as hanging droplets for 2 days to allow
HEK293 cell spheroid formation, neighboring spots were
merged by adding 1 ml DMEM to each spot (e.g. A1 and A2).
The resulting fused spheroids were then analyzed by fluores-
cence microscopy (Zeiss LSM 800 confocal fluorescent micro-
scope) 24 h and 48 h after merging.
NanoBRET binding assay
DFZD1–10 HEK293 cells (34) were transiently transfected in
suspension using Lipofectamine® 2000 (Thermo Fisher Scien-
tific). A total of 4 3 105 cells were transfected in 1 ml with 10
ng of Nluc-tagged receptor plasmid DNA or 100 ng of HiBiT-
tagged receptor plasmid DNA and 990 or 900 ng of pcDNA
plasmid DNA. The cells (100 ml) were seeded onto a poly-D-ly-
sine-coated black 96-well cell culture plate with a solid flat bot-
tom (Greiner BioOne). Twenty-four hours posttransfection,
the cells were washed once with 200 ml of Hanks’ balanced salt
solution (HBSS; HyClone). In the kinetics experiments, the cells
were preincubated with 50 ml of the Nluc substrate vivazine
(1:50 dilution; Promega) in a complete, non-phenol red DMEM
(HyClone) supplemented with 10 mM HEPES for 1 h at 37 °C
without CO2. Subsequently, 50 ml of eGFP-Wnt-3a conditioned
medium or control medium supplemented with 10 mM HEPES
was added, and the BRET signal was measured every 60 s for
180 min at 37 °C (181 measurements, no CO2). In the satura-
tion-binding experiments, the cells were incubated with differ-
ent concentrations of eGFP-Wnt-3a conditioned medium (90
ml) supplemented with 10 mM HEPES for 120 min at 37 °C with
no CO2. Next, for the Nluc-tagged constructs, 10 ml of the Nluc
substrate furimazine was added (1:100 dilution; Promega), and
for the HiBiT-tagged constructs, 90 ml of a mix of furimazine
(1:100 dilution; Promega) and LgBiT (1:200 dilution; Promega)
was added. The cells were incubated for another 10 min prior to
the BRETmeasurements. The BRET ratio was determined as the
ratio of light emitted by eGFP (energy acceptor) and light emit-
ted by Nluc/HiBiT-tagged receptors (energy donors). The BRET
acceptor (bandpass filter, 535–30 nm) and BRET donor (band-
pass filter, 475–30 nm) emission signals were measured using a
CLARIOstar microplate reader (BMG). eGFP fluorescence was
measured prior to reading BRET (excitation, 470–15 nm; emis-
sion, 515–20 nm). Data were analyzed using GraphPad Prism 6.
Bystander BRET receptor internalization assay
Parental and DFZD1–10 HEK293 cells were transiently trans-
fected in suspension using Lipofectamine® 2000. 200 ng of
b2AR-Nluc or FZD4-Nluc plasmid DNA was added along with
800 ng DNA of the membrane-anchored HaloTag construct to
a cell suspension of 43 105 cells per ml. One hundred microli-
ters of cell suspension was plated in white 96-well cell culture
plates with solid flat bottoms (Greiner BioOne). Twenty-four
hours after transfection, HaloTag® NanoBRETTM 618 ligand
(Promega) was added to each well to a final concentration of 50
nM. Forty-eight hours posttransfection, cells were washed with
100 ml HBSS incubated in 90 ml Nluc substrate furimazine in
HBSS (1:1,000 dilution; Promega) for 2 to 5 min. Subsequently,
baseline BRET was recorded in three consecutive reads. Next,
10 ml of vehicle control or 10-fold ligand, recombinant human
Wnt-3a (RnD) or isoprenaline (Sigma), solution was added, and
BRET was recorded for an additional 2 h. BRET measurements
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were conducted at 37 °C using a CLARIOstar microplate reader
(BMG) equipped with monochromators to separate light emit-
ted by C-terminally Nluc-tagged receptors (420–480 nm;
energy donor) and the membrane-anchored red fluorescent
HaloTag® NanoBRETTM 618 ligand (600–660 nm; energy
acceptor). The cycle time was set to 2 min with an integration
time of 0.3 s. BRET ratio was defined as emission intensity of
HaloTag® NanoBRETTM 618 Ligand over Nluc and analyzed
using GraphPad Prism 6.
Live-cell ELISA
For quantification of cell surface receptor expression by
labeling with anti-Nluc antibody, DFZD1–10 HEK293 cells at a
density of 43 105 cells/ml were transfected in suspension using
Lipofectamine® 2000 with 10 ng of the indicated receptor plas-
mid DNA and 990 ng of pcDNA plasmid DNA. The cells (100
ml) were seeded onto a PDL-coated transparent 96-well plate
with a flat bottom and grown overnight. Twenty-four hours
later, the cells were washed once with 0.5% BSA in PBS and
incubated with a mouse anti-Nluc (2 mg/ml, MAB10026; RnD
Systems) in 1% BSA–PBS for 1 h at 4 °C. Following incubation,
the cells were washed three times with 0.5% BSA–PBS and
incubated with a horseradish peroxidase-conjugated goat anti-
mouse antibody (1:3,000, no. 31430; Thermo Fisher Scientific)
in 1% BSA–PBS for 1 h at 4 °C. The cells were washed three
times with 0.5% BSA/PBS, and 50 ml of the peroxidase substrate
3,39,5,59-tetramethylbenzidine (T8665; Sigma-Aldrich) was
added. The cells were incubated further for 20 min, and upon de-
velopment of a blue product, 50 ml of 2MHCl was added and the
absorbance was read at 450 nm using a BMGV POLARstar plate
reader. The data were analyzed inGraphPad Prism 6.
Data and statistical analysis
For the TOPFLASH reporter assays shown in Fig. 1b, 3a, and
4c, as well as Fig. S1d and Fig. S4a, error bars show standard devi-
ation from the means (6S.D.) of n 5 4 independent biological
samples within an experiment, and all experiments were per-
formed at least 3 times, unless indicated otherwise. For the TOP-
FLASH assay in Fig. 2c, the error bars show standard deviations
from themeans (6 S.D.) from n5 5 independent biological sam-
ples. The experiment was performed twice with similar results.
For the NanoBRET binding data presented, the eGFP-Wnt-3a
saturation binding curves were fitted using a three- or four-pa-
rameter nonlinear regression model. The binding curves repre-
sent mean 6 S.E. of the mean from three independent experi-
ments, each performed in two technical replicates. Affinity values
are presented as a best-fit Kd 6 S.D. A one-phase association
model was used to analyze eGFP-Wnt-3a binding kinetics data:
Y ¼ Y0 1 plateau Y0ð Þ3 ð1 e kobsxð ÞÞ
NanoBRET binding models were selected based on an extra-
sum-of-square F-test (p , 0.05). NanoBRET binding data for
Nluc-FZD6, Nluc-SMO, andNluc-FZD4 (Fig. S5) were analyzed
for differences with unpaired t tests to compare raw BRET
ratios of eGFP-Wnt-3a medium binding with control medium
binding for each construct.
Live-cell ELISA data were analyzed using GraphPad Prism 6
and representmeans6 S.E. of three individual experiments (bi-
ological replicates) performed in triplicates (technical repli-
cates). Live-cell ELISA data were analyzed for differences with
one-way analysis of variance with Fisher’s least significant dif-
ference post hoc analysis. Significance levels (p , 0.0001) are
indicated by asterisks or hashtags.
Data availability
Data supporting the findings of this manuscript are available
from the corresponding authors upon reasonable request.
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